Literature DB >> 2643463

Complexity of MAM-6, an epithelial sialomucin associated with carcinomas.

J Hilkens1, F Buijs, M Ligtenberg.   

Abstract

The complexity of epithelial sialomucins was investigated by immunoprecipitation and membrane immunofluorescence, using monoclonal antibodies (MAbs) against MAM-6 and other sialomucins. MAbs against MAM-6 immunoprecipitated from a variety of sources either one or two sialylated glycoproteins with apparent molecular weights of over 400,000 under reducing as well as nonreducing conditions. The electrophoretic mobility of each MAM-6 glycoprotein as isolated from serum, milk, and cell lines of different individuals showed considerable variation. The differences in molecular weight of the MAM-6 glycoproteins were also reflected at the level of MAM-6 precursors which are less heavily glycosylated. Therefore, large differences in apparent molecular weight (150,000 and over) are most likely due to a variable protein backbone. We used this molecular polymorphism to prove that 11 MAbs against different sialomucins, obtained from various investigators, precipitated sialomucins generated from common precursor molecules. The pattern of reactivity of the MAbs with carcinoma cell lines was complex. All but the two MAbs, directed against putative carbohydrate epitopes, immunoprecipitated the precursor molecule from each cell line. However, some of them were unable to immunoprecipitate the mature form of MAM-6 from these cell lines. These results indicate that those epitopes are masked, probably due to cell line- or possibly cell type-dependent variations in glycosylation of the epithelial sialomucin. Even within a single cell line mature molecules with different epitopes were observed. The differential reactivity of the MAbs was confirmed by membrane immunofluorescence. These results show that MAM-6 belongs to a family of epithelial sialomucins with a polymorphic protein backbone and extensive variation in glycosylation.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2643463

Source DB:  PubMed          Journal:  Cancer Res        ISSN: 0008-5472            Impact factor:   12.701


  13 in total

1.  Interaction with basement membrane serves to rapidly distinguish growth and differentiation pattern of normal and malignant human breast epithelial cells.

Authors:  O W Petersen; L Rønnov-Jessen; A R Howlett; M J Bissell
Journal:  Proc Natl Acad Sci U S A       Date:  1992-10-01       Impact factor: 11.205

2.  Immunohistochemical distribution of MAM-3 and MAM-6 antigens in developing salivary glands of the human fetus.

Authors:  S K Lee; C Y Lim; J G Chi; K Yamada; M Mori; A Tsubura; S Morii; J Hilgers; M Govindarajan
Journal:  Histochem J       Date:  1991-08

Review 3.  Mucin glycoproteins in neoplasia.

Authors:  Y S Kim; J Gum; I Brockhausen
Journal:  Glycoconj J       Date:  1996-10       Impact factor: 2.916

4.  Altered mucin core peptide expression in acute and chronic cholecystitis.

Authors:  S B Ho; L L Shekels; N W Toribara; I K Gipson; Y S Kim; P P Purdum; D L Cherwitz
Journal:  Dig Dis Sci       Date:  2000-06       Impact factor: 3.199

5.  MUC1 (EMA) is preferentially expressed by ALK positive anaplastic large cell lymphoma, in the normally glycosylated or only partly hypoglycosylated form.

Authors:  R L ten Berge; F G Snijdewint; S von Mensdorff-Pouilly; R J Poort-Keesom; J J Oudejans; J W Meijer; R Willemze; J Hilgers; C J Meijer
Journal:  J Clin Pathol       Date:  2001-12       Impact factor: 3.411

6.  Topographical investigations of human ovarian-carcinoma polymorphic epithelial mucin by scanning tunnelling microscopy.

Authors:  C J Roberts; M Sekowski; M C Davies; D E Jackson; M R Price; S J Tendler
Journal:  Biochem J       Date:  1992-04-01       Impact factor: 3.857

Review 7.  Transmembrane Mucins: Signaling Receptors at the Intersection of Inflammation and Cancer.

Authors:  Jos P M van Putten; Karin Strijbis
Journal:  J Innate Immun       Date:  2017-01-05       Impact factor: 7.349

8.  Carcinoma-associated monoclonal antibodies in head and neck carcinoma. Immunohistochemistry and biodistribution of monoclonal antibodies 175F4 and 175F11.

Authors:  A J Balm; P C Hageman; C L Mulder; J Hilkens
Journal:  Eur Arch Otorhinolaryngol       Date:  1992       Impact factor: 2.503

9.  Circulating tumor-associated antigens detected by monoclonal antibodies against the polypeptide core of mucin--comparison of antigen MUSE11 with CA15-3.

Authors:  Y Hinoda; H Kakiuchi; N Nakagawa; Y Ohe; T Sugiyama; M Tsujisaki; K Imai; A Yachi
Journal:  Gastroenterol Jpn       Date:  1992-06

10.  Pharmacokinetics and biodistribution of a new anti-episialin monoclonal antibody 139H2 in ovarian-cancer-bearing nude mice.

Authors:  C F Molthoff; H M Pinedo; H M Schlüper; E Boven
Journal:  Cancer Immunol Immunother       Date:  1991       Impact factor: 6.968

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.